The drug distribution space is probably too often overlooked by investors. In that domain, you have some central growth themes inextricably tied into the equation […]
It appears increasingly official as a piece of cultural news: the pandemic is far from over. What’s more, policymakers are starting to officially authorize booster […]
The vaccine is now a defining part of the world economy, with Evercore analysts predicting the first round of vaccinations (ie, those taking place this […]
The big step from here is an improvement and normalization in terms of our relationship with healthcare. But, because of what we have all endured […]
The market is ripping higher. But one of the most important leadership areas isn’t what most retail investors generally think about when they think of […]
CVS Health Corp (NYSE:CVS) has announced that will no longer sell heartburn drug Zantac which the FDA is investigating for links to cancer. The company […]
With the 2018 U.S. Farm Bill unshackling hemp from its cousin cannabis and making hemp legal from coast-to-coast, farmers across the country began positioning for […]
